Holen Sie sich die Stockscreener-App
118.21
0.44%
-0.52
Handel nachbörslich:
118.21
Finanzdaten der Haemonetics Corp-Aktie (HAE)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-27 | 2026-03-28 | 2025-12-27 | 2025-09-27 | 2025-06-28 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
2.01%
339.38
|
346.35 | 338.97 | 327.31 | 321.39 |
| Cost Of Revenue |
7.80%
136.58
|
148.14 | 136.58 | 132.57 | 129.15 |
| Gross Profit |
2.32%
202.80
|
198.21 | 202.39 | 194.74 | 192.24 |
Operating Expenses
|
34.30%
145.34
|
221.24 | 134.99 | 136.25 | 138.37 |
| Depreciation and Amortization |
0.76%
27.11
|
27.32 | 27.39 | 28.25 | 28.76 |
| Operating Income/Loss |
349.55%
57.46
|
-23.02 | 67.40 | 58.49 | 53.87 |
| Income/Loss From Equity Method Investments |
-1.00
|
- | - | - | - |
| Income/Loss From Continuing Operations Before Tax |
267.52%
47.57
|
-28.40 | 59.98 | 51.28 | 45.17 |
| Income Tax Expense/Benefit, Deferred |
103.28%
0.668
|
-20.38 | -2.062 | -0.725 | -3.231 |
| Income Tax Expense/Benefit |
276.49%
14.56
|
-8.252 | 15.23 | 12.60 | 11.14 |
| Net Income/Loss |
263.85%
33.01
|
-20.15 | 44.74 | 38.68 | 34.03 |
| Basic Average Shares |
45.36
|
- | 46.79 | 47.59 | 48.11 |
| Diluted Average Shares |
45.70
|
- | 46.99 | 47.66 | 48.35 |
| Basic Earnings Per Share |
0.73
|
- | 0.96 | 0.81 | 0.71 |
| Diluted Earnings Per Share |
0.72
|
- | 0.95 | 0.81 | 0.70 |
2.01%
0.04%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):